Illumina reagent chemistry kits
Ended Awarded Last action
- Contract number
- 75F40125F19047
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $177,986
Award facts
- Contract value 100% obligated
- $177,986.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$390 | |
| Original award | $178,377 |
About this award
The Food and Drug Administration awarded a delivery order to Illumina, Inc. for Illumina Reagent Chemistry Kits valued at $177,986.33 under a Firm Fixed Price contract type. The award, issued on January 15, 2025, with an ultimate completion date of March 31, 2025, represents a modification to de-obligate funds and close out the contract. The work will be performed in Laurel, Maryland, and no set-aside designation was utilized for this procurement. Illumina, Inc., a leading biotechnology company headquartered in San Diego, California, specializes in genetic sequencing and genomic analysis technologies, providing critical reagent kits and related consumables to federal agencies for research and diagnostic applications.
This delivery order supports the FDA's scientific research and diagnostic capabilities through the provision of specialized reagent chemistry kits used in DNA and RNA sequencing operations. Illumina has an established track record of federal contracting across multiple civilian agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Agriculture, consistently delivering advanced genomic sequencing technologies without set-aside restrictions. The contract modification's focus on de-obligation and closeout indicates the completion of the original procurement objective, with the final performance scheduled for completion by March 31, 2025.
Quick answers
Who was awarded contract 75F40125F19047?
75F40125F19047 was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on January 15, 2025.
How much is contract 75F40125F19047 worth?
The government has obligated $177,986 on 75F40125F19047.
Is contract 75F40125F19047 an order under another contract?
Yes. 75F40125F19047 is a delivery order under 75F40123D00001, an indefinite delivery contract.
Was contract 75F40125F19047 competed?
The extent of competition for 75F40125F19047 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award